Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli

Dengue vaccines: progress and challenges

(2011) Beth-Ann G Coller et al.   CURRENT OPINION IN IMMUNOLOGY

Balance of infection-enhancing and neutralizing antibodies induced by a dengue tetravalent DNA vaccine in a mouse model

(2011) Eiji Konishi et al.   MICROBES AND INFECTION

A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein

(2011) Yong-Qiang Deng et al.   PLoS One

Dengue Virus

(2010) Ted M. Ross   CLINICS IN LABORATORY MEDICINE

Mosquito-Borne Hemorrhagic Fevers

(2010) Omar Lupi   DERMATOLOGIC CLINICS

Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris

(2010) Gaurav Batra et al.   JOURNAL OF BIOSCIENCE AND BIOENGINEERING

Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies

(2010) Gaurav Batra et al.   JOURNAL OF VIROLOGICAL METHODS

Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen

(2010) Gaurav Batra et al.   PROTEIN EXPRESSION AND PURIFICATION

Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

(2010) W. Dejnirattisai et al.   SCIENCE

A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice

(2010) Olivia K.T. Block et al.   VACCINE

Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes

(2010) Steven M. Erb et al.   VIROLOGY

Roles of Small GTPase Rac1 in the Regulation of Actin Cytoskeleton during Dengue Virus Infection

(2010) Jia-Li Wang et al.   PLoS Neglected Tropical Diseases

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1

(2010) Bimmi Shrestha et al.   PLoS Pathogens

Development of a novel DNA SynCon™ tetravalent dengue vaccine that elicits immune responses against four serotypes

(2009) Mathura P. Ramanathan et al.   VACCINE

Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development

(2008) Theodore C. Pierson et al.   Cell Host & Microbe

Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus

(2008) G. D. Gromowski et al.   JOURNAL OF VIROLOGY

Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen

(2008) Adrian C.N. Sim et al.   VACCINE